To identify a protease signature of nonalcoholic steatohepatitis (NASH), transcriptomic analysis of 355 human liver biopsies identified a 13-protease panel that discriminated clinically relevant NASH ≥F2 fibrosis from F0-F1 with high classification accuracy across two independent patient datasets.
[Science Translational Medicine]
7992332
{7992332:CCCCCCCC}
apa
50
1
168011
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/